Compare Bio Protocol (BIO) vs Polymesh (POLYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Polymesh — how do they compare? Bio Protocol trades at Rp442.8 (market cap Rp1T, Rp177,9M 24h volume), while Polymesh trades at Rp527.93 (market cap Rp699,51M, Rp22,08M 24h volume). The key difference: Bio Protocol is far larger — about 1429.6× Polymesh's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Polymesh's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Polymesh for 20 Days on average.
| BIO | POLYX | |
|---|---|---|
Market Cap | Rp1T | Rp699,51M |
Volume (24h) | Rp177,9M | Rp22,08M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,1B POLYX |
Typical Hold Time | 17 Days | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
POLYX is trading at Rp525.16 with bearish technical signals from moving averages but bullish oscillators, suggesting potential near-term recovery. The token faces resistance at Rp551 and support at Rp514. With a market cap of Rp699.51M and limited circulating supply of 1.1M tokens, liquidity remains constrained. No major protocol updates or ecosystem developments were noted in recent analysis.
Overall outlook remains cautious with technical indicators mixed. Key opportunities include oversold RSI levels suggesting potential bounce, while major risks include low liquidity and bearish trend dominance. Investors should monitor volume patterns and network activity for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Polymesh
POLYX is the native protocol token of Polymesh, an institutional-grade permissioned blockchain built specifically for regulated assets. It streamlines antiquated processes and opens the door to new financial instruments by solving challenges with public infrastructure around governance, identity, compliance, confidentiality, and settlement. The token can be used to stake and secure the network, pay transaction fees, and engage in governance.
Read more on POLYX →
